From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy.
View/ Open
Date
2022-05-01Author
Yarnold, JR
Brunt, AM
Chatterjee, S
Somaiah, N
Kirby, AM
Type
Journal Article
Metadata
Show full item recordAbstract
There is a sound empirical basis for hypofractionation in radiotherapy for breast cancer. This article reviews the radiobiological implications of hypofractionation in breast cancer derived from a series of clinical trials that began when 50 Gy in 25 fractions over 5 weeks was commonplace. These trials led first to 40 Gy in 15 fractions over 3 weeks and, subsequently, to 26 Gy in five fractions over 1 week being adopted as standards of care for many patients prescribed whole- or partial-breast radiotherapy after primary surgery.
Collections
Subject
Breast
Humans
Breast Neoplasms
Treatment Outcome
Radiotherapy, Adjuvant
Female
Radiation Dose Hypofractionation
Research team
Breast Cancer Radiotherapy
Translational Breast Radiobiology
Language
eng
Date accepted
2022-03-01
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2022, 34 (5), pp. 332 - 339
Publisher
ELSEVIER SCIENCE LONDON